LB Pharmaceuticals Inc
LB Pharmaceuticals Inc scores highest on Nitro (78) and lowest on Price (19). Its PosiPenta is 46.96 out of 100, around the middle of similar companies.
On the Penta Grid this week, LB Pharmaceuticals Inc is Grid #341 of 837 in the Healthcare sector in United States, and Grid #2,226 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| LB Pharmaceuticals Inc | 46.96 | 19 | 38 | 78 | 60 | 40 |
| Rapport Therapeutics, Inc. | 38.71 | 21 | 17 | 45 | 61 | 50 |
| Enovis Corporation | 42.47 | 42 | 44 | 50 | 33 | 42 |
| InnovAge Holding Corp. | 61.51 | 13 | 87 | 74 | 56 | 77 |
| Taysha Gene Therapies, Inc. | 40.74 | 21 | 41 | 37 | 48 | 56 |
| GoodRx Holdings, Inc. | 61.84 | 38 | 86 | 84 | 49 | 51 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 367.40 |
| P/B ratio | 3.57 |
EEarnings
| Trailing EPS | ₹9.47 |
| Forward EPS | ₹-486.10 |
NNitro
| Price | 3479.83 |
| 52-week high | 4750.90 |
| 52-week low | 1356.03 |
| Fall from 52-week high | 26.8% |
TTorque
| Return on equity (ROE) | -50.00% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹11,225 Cr |
| Insider holding | 0.24% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is LB Pharmaceuticals Inc's PosiPenta score?
LB Pharmaceuticals Inc's PosiPenta is 46.96 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does LB Pharmaceuticals Inc stand on the Penta Grid?
On the Penta Grid this week, LB Pharmaceuticals Inc is Grid #341 of 837 in the Healthcare sector in United States, and Grid #2,226 of 4,000 in United States.
Which PosiPenta pillar is strongest for LB Pharmaceuticals Inc?
Nitro (momentum), with a score of 78 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for LB Pharmaceuticals Inc?
Price (valuation), with a score of 19 out of 100: much weaker than most similar companies.
Has LB Pharmaceuticals Inc's PosiPenta changed since last week?
Yes, it rose 3.95 points, from 43.01 to 46.96.
PositoAI is for research and education only and is not investment advice.